Conquering Diseases

A Study Of An Investigational Drug In Patients With A Specific Kind Of Blood Cancer (G043693)


Seeking men and women over 18 years of age who have relapsed or refratory B-cell lymphoma after first line chemoimmunotherapy for participation in a study looking at an investigational drug in combination with other drugs


We are studying the effect of an investigational drug called glofitamab and how well it works and how safe it is, in combination with other drugs, for patients with a specfic kind of blood cancer called B-Cell Lymphoma.

What we're hoping for

To evaluate how safe and how well the investigational drug glofitamab works in combination with other drugs in patients with this specific kind of blood cancer.

Additional Information Identifier: NCT05364424

 Principal Investigator

Andrew  Gillis-Smith, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office



UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655